{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T04:40:02Z","timestamp":1752208802048,"version":"3.41.2"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>The finding of liver metastases in thyroid cancer is relatively uncommon. Treatment is complex and depends on several factors, including location, number and size of lesions, associated symptoms, extrahepatic disease and patient\u2019s condition. In this context, interventional radiological treatments have been successfully used to optimize disease control or for palliative purposes and have generally been well tolerated. However, careful selection of candidates for such procedures in a multidisciplinary context is crucial.<\/jats:p>","DOI":"10.3389\/fendo.2025.1445855","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T04:10:26Z","timestamp":1752207026000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Navigating the complexity of current interventional radiological approaches for distant metastases in thyroid cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Daqi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry","family":"Spisani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Ceriello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Frattini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Brucchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianlorenzo","family":"Dionigi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanlan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio\u00a0Salvatore","family":"Angileri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Ierardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianpaolo","family":"Carrafiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO classification of thyroid neoplasms","volume":"33","author":"Baloch","year":"2022","journal-title":"Endocr Pathol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2838","article-title":"Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy","volume":"91","author":"Durante","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2018.0597","article-title":"Controversies, consensus, and collaboration in the use of 131I therapy in differentiated thyroid cancer: a joint statement from the American thyroid association, the European association of nuclear medicine, the society of nuclear medicine and molecular imaging, and the European thyroid association","volume":"29","author":"Tuttle","year":"2019","journal-title":"Thyroid"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e990","DOI":"10.1634\/theoncologist.2018-0337","article-title":"Radiofrequency ablation and microwave ablation in liver tumors: an update","volume":"24","author":"Izzo","year":"2019","journal-title":"Oncologist"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-009-9736-y","article-title":"Quality improvement guidelines for radiofrequency ablation of liver tumors","volume":"33","author":"Crocetti","year":"2010","journal-title":"Cardiovasc Interv Radiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-013-0130-9","article-title":"Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors","volume":"47","author":"Fiore","year":"2014","journal-title":"Endocr"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-021-00646-6","article-title":"Interventional radiology approaches for liver metastases from thyroid cancer: a case series and overview of the literature","volume":"52","author":"Nervo","year":"2021","journal-title":"J Gastrointest Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e220130","DOI":"10.1530\/ETJ-22-0130","article-title":"Yttrium-90 transarterial radioembolization for liver metastases from medullary thyroid cancer","volume":"11","author":"Puleo","year":"2022","journal-title":"Eur Thyroid J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"300891620952844","DOI":"10.1177\/0300891620952844","article-title":"Local therapies for liver metastases of rare head and neck cancers: a monoinstitutional case series","volume":"2020","author":"Bergamini","year":"2020","journal-title":"Tumori"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0960","article-title":"The role of hepatic trans-arterial chemoembolization in metastatic medullary thyroid carcinoma: a specialist center experience and review of the literature","volume":"176","author":"Grozinsky-Glasberg","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.surg.2010.09.014","article-title":"Laparoscopic radiofrequency thermal ablation of neuroendocrine hepatic metastases: long-term follow-up","volume":"148","author":"Akyildiz","year":"2010","journal-title":"Surgery"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2007.01.036","article-title":"Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival","volume":"142","author":"Mazzaglia","year":"2007","journal-title":"Surgery"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2401","article-title":"Chemoembolization for liver metastases from medullary thyroid carcinoma","volume":"91","author":"Fromigu\u00e9","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2005.09.020","article-title":"Selective arterial chemoembolization for hepatic metastases from medullary thyroid carcinoma","volume":"138","author":"Lorenz","year":"2005","journal-title":"Surgery"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-002-6629-5","article-title":"Laparoscopic radiofrequency ablation of neuroendocrine liver metastases","volume":"26","author":"Berber","year":"2002","journal-title":"World J Surg"},{"key":"B16","volume-title":"Common Terminology Criteria for Adverse Events (CTCAE)Version 5.0","year":"2017"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1673.2007.01871.x","article-title":"Post-radiofrequency ablation syndrome after percutaneous radiofrequency of abdominal tumors: one center experience and review of published works","volume":"51","author":"Carrafiello","year":"2007","journal-title":"Australas Radiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-018-2032-y","article-title":"Intra-caval percutaneous radiofrequency ablation for a neuroendocrine tumor (NET) metastasis in transplanted liver","volume":"41","author":"Ierardi","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-013-0968-1","article-title":"Microwave ablation of liver metastases to overcome the limitations of radiofrequency ablation","volume":"118","author":"Ierardi","year":"2013","journal-title":"Radiol Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1999.9.173","article-title":"Severe thyrotoxicosis due to hyperfunctioning liver metastasis from follicular carcinoma: treatment with 131I and interstitial laser ablation","volume":"9","author":"Guglielmi","year":"1999","journal-title":"Thyroid"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000002763","article-title":"Selective internal radiation therapy for liver metastasis of papillary thyroid carcinoma","volume":"45","author":"Kesim","year":"2020","journal-title":"Clin Nucl Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"B23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz400","article-title":"Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Filetti","year":"2019","journal-title":"Ann Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1159\/000502229","article-title":"2019 European Thyroid Association guidelines for the treatment and follow-up of advanced radioiodine-refractory thyroid cancer","volume":"8","author":"Fugazzola","year":"2019","journal-title":"Eur Thyroid J"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1159\/000516469","article-title":"European Thyroid Association and Cardiovascular and Interventional Radiological Society of Europe 2021 clinical practice guideline for the use of minimally invasive treatments in Malignant thyroid lesions","volume":"10","author":"Mauri","year":"2021","journal-title":"Eur Thyroid J"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-17-0389","article-title":"Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patients","volume":"25","author":"Romeo","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-023-03610-5","article-title":"Improved guidance is needed to optimize diagnostics and treatment of patients with thyroid cancer in Europe","volume":"83","author":"de la Fouchardi\u00e8re","year":"2024","journal-title":"Endocrine"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-011-0697-2","article-title":"Ultrasound-guided thermal radiofrequency ablation (RFA) as an adjunct to systemic chemotherapy for breast cancer liver metastases","volume":"116","author":"Carrafiello","year":"2011","journal-title":"Radiol Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02477-0","article-title":"Lenvatinib as first-line treatment for advanced thyroid cancer: long progression-free survival","volume":"72","author":"De Leo","year":"2021","journal-title":"Endocrine"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1159\/000502229","article-title":"2019 European thyroid association guidelines for the treatment and follow-up of advanced radioiodine-refractory thyroid cancer","volume":"8","author":"Fugazzola","year":"2019","journal-title":"Eur Thyroid J"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-15-0252","article-title":"Safety and tolerability of sorafenib in patients with radioiodine-refractory thyroid cancer","volume":"22","author":"Worden","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s10439-025-03698-y","article-title":"Identification of novel biomarkers for Malignant thyroid nodules: A preliminary study based on ultrasound omics","volume":"53","author":"Li","year":"2025","journal-title":"Ann BioMed Eng"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-024-02467-3","article-title":"Serum microRNA-146a-5p and microRNA-221-3p as potential clinical biomarkers for papillary thyroid carcinoma","volume":"48","author":"Verrienti","year":"2025","journal-title":"J Endocrinol Invest"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-024-10854-w","article-title":"Dual-source dual- energy CT and deep learning for equivocal lymph nodes on CT images for thyroid cancer","volume":"34","author":"Li","year":"2024","journal-title":"Eur Radiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.2174\/0118715303264254231117113456","article-title":"The application of artificial intelligence in thyroid nodules: A systematic review based on bibliometric analysis","volume":"24","author":"Peng","year":"2024","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-023-03407-6","article-title":"A machine learning-based sonomics for prediction of thyroid nodule Malignancies","volume":"82","author":"Arabi","year":"2023","journal-title":"Endocrine"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-023-02115-2","article-title":"Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients","volume":"46","author":"Besharat","year":"2023","journal-title":"J Endocrinol Invest"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-22-0006","article-title":"Advanced RAI-refractory thyroid cancer: an update on treatment perspectives","volume":"29","author":"Karapanou","year":"2022","journal-title":"Endocr Relat Cancer"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2022.101655","article-title":"Medullary thyroid cancer - An update","volume":"37","author":"Fugazzola","year":"2023","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.31486\/toj.20.0067","article-title":"Metastatic papillary thyroid cancer to the liver: the central role of a multidisciplinary approach to treatment","volume":"21","author":"Riker","year":"2021","journal-title":"Ochsner J"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1445855\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T04:10:27Z","timestamp":1752207027000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1445855\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":41,"alternative-id":["10.3389\/fendo.2025.1445855"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1445855","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]},"article-number":"1445855"}}